DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Nexavar (Sorafenib) - Current Clinical Trials

 
 



Nexavar Related Clinical Trials

Sorafenib With BIIB022 in Hepatocellular Carcinoma (HCC) [Completed]

Phase I/II, Study of Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) + Sorafenib in Acute Myeloid Leukemia [Not yet recruiting]

Nexavar Post-marketing Surveillance for Renal Cell Carcinoma in Japan [Completed]

Nexavar Post-marketing Surveillance for RCC in Japan: Early Access Program [Completed]

Nexavar Post-marketing Surveillance for Hepatocellular Carcinoma in Japan [Completed]

Sorafenib or Crizotinib and Vemurafenib in Advanced Cancer [Recruiting]

Phase I/II Trial of RAD001 Plus Nexavar in Patients With Kidney Cancer [Completed]

Sorafenib and Yttrium-90 Glass Microspheres for Advanced Hepatocellular Carcinoma (HCC) [Recruiting]

Sorafenib Dose Ramp-Up in Hepatocellular Carcinoma (HCC) [Completed]

Second Line Sorafenib After Pazopanib in Patients With RCC [Not yet recruiting]

Sorafenib and Radiotherapy in the Treatment of Invasive Bladder Cancer With Conservative Intent [Completed]

Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma [Not yet recruiting]

Sorafenib Plus 5-Azacitidine Initial Therapy of Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MS) With FLT3-ITD Mutation [Recruiting]

Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma [Withdrawn]

Sorafenib and 5-Azacitidine in Acute Leukemia + Myelodysplastic Syndrome [Completed]

Sorafenib Concurrent With Yttrium-90 Transarterial Radioembolization in Patients With Advanced Hepatocellular Cancer [Recruiting]

Study to Determine the Safety, Maximum Tolerated Dose, Pharmacokinetics of Sorafenib (BAY43-9006) [Completed]

Sorafenib With Capecitabine for Patients With Measurable Hepatocellular Carcinoma [Terminated]

Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancer [Active, not recruiting]

Sorafenib as Neoadjuvant Therapy Before Cytoreductive Nephrectomy in Patients With Metastatic Renal Cell Carcinoma [Recruiting]

Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer [Completed]

Effect of Sorafenib on ccRCC Uptake of Radiolabeled Bevacizumab or cG250 [Completed]

Phase I-II Everolimus and Sorafenib in Recurrent High-Grade Gliomas [Recruiting]

PEG-Interferon Alfa-2b and Sorafenib in Treating Patients With Unresectable or Metastatic Kidney Cancer [Terminated]

Pre-operative Administration of Sorafenib in Patients With Metastatic Renal Cell Carcinoma Undergoing Kidney Removal [Completed]

Study of Combination of Metronomic Oral Vinorelbine and Sorafenib in Patients With Advanced Non-small Cell Lung Cancer [Completed]

Sorafenib for Patients With Metastatic or Recurrent Esophageal and Gastroesophageal Junction Cancer [Active, not recruiting]

Study of Curcumin, Vorinostat, and Sorafenib [Withdrawn]

Nexavar-Tarceva Combination Therapy for First Line Treatment of Patients Diagnosed With Hepatocellular Carcinoma [Active, not recruiting]

Sorafenib Chemoembolization Evaluation Controlled Trial [Recruiting]

Phase I Trial of Sorafenib + FOLFIRI In Metastatic Colorectal Cancer [Completed]

Randomized Phase 1/2 Open-Label Trial of PR104 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC) [Terminated]

SORAVE - Sorafenib and Everolimus in Solid Tumors [Recruiting]

Sorafenib in Treating Patients Who Are Undergoing Surgery for Metastatic Kidney Cancer [Terminated]

Efficacy and Safety of Concurrent TACE and Sorafenib in Patients With HCC and Extrahepatic Metastasis (COTSOM Study) [Recruiting]

Efficacy and Safety of Sorafenib in Advanced Renal Cell Carcinoma (RCC) [Completed]

Prospective, Non-interventional, Post-authorization Safety Study That Includes All Patients Diagnosed as Unresectable Differentiated Thyroid Carcinoma and Treated With Sorafenib [Recruiting]

Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma [Completed]

Ph. 2 Sorafenib + Protracted Temozolomide in Recurrent GBM [Completed]

Sorafenib and Cyclophosphamide/Topotecan in Patients With Relapsed and Refractory Neuroblastoma [Recruiting]

Sorafenib Plus Tegafur-uracil (UFT) Versus Sorafenib as First Line Systemic Treatment for Patients With Advanced Stage HCC, Unresectable & Not Eligible for Local Ablation and/or TACE [Terminated]

Sorafenib for Patients With Extensive Keloids [Terminated]

Sorafenib for Hepatopulmonary Syndrome [Recruiting]

Comparing Efficacy of Sorafenib Versus Sorafenib in Combination With Low-dose FP in Patients With Advanced HCC [Recruiting]

AZD6244 and Sorafenib in Advanced Hepatocellular Carcinoma [Terminated]

A Phase II Study Of Abraxane and Nexavar in the First-Line Treatment of Locally Advanced or Metastatic Breast Cancer [Terminated]

Granulocyte-colony Stimulating Factor (G-CSF) and Plerixafor Plus Sorafenib for Acute Myelogenous Leukemia (AML) With FLT3 Mutations [Active, not recruiting]

Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or Melanoma [Recruiting]

Intra-patient Dose Escalation Study of Sorafenib in Advanced Non-small Cell Lung Cancer [Active, not recruiting]

Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer [Active, not recruiting]

Efficacy and Safety of Sorafenib (Nexavar) in Combination With Gemcitabine in Advanced Hepatocellular Carcinoma (HCC) [Completed]

Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal Cancer [Completed]

Y-90 Alone or With Sorafenib for Pre-Transplant Hepatocellular Carcinoma [Active, not recruiting]

Study of the Pharmacokinetics/Safety of Sorafenib + Capecitabine in Advanced Solid Tumors [Completed]

Phase II Open Label, Non-randomized Study of Sorafenib and Everolimus in Relapsed and Non-resectable Osteosarcoma [Completed]

Study Adding Multikinase Inhibitor Sorafenib to Existing Endocrine Therapy in Patients With Advanced Breast Cancer [Terminated]

A Phase I Trial Evaluating mFOLFOX6 and Avastin With Nexavar as First-Line Treatment for Metastatic Colorectal Cancer [Terminated]

Radiation Therapy With Sorafenib for TACE-Resistant Hepatocellular Carcinoma [Withdrawn]

Sorafenib in Children and Young Adults With Recurrent or Progressive Low-Grade Astrocytomas [Suspended]

Sorafenib and Erlotinib or Sorafenib Alone in Advanced Non-Small Cell Lung Cancer Progressing on Erlotinib [Completed]

Combination of Sorafenib and Vorinostat in Poor-risk Acute Myelogenous Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS) [Completed]

Neoadjuvant Sorafenib Therapy Prior to Laser Ablation for Hepatocellular Carcinoma [Recruiting]

Study of Sorafenib, Gemcitabine, and Cisplatin in Advanced Hepatocellular Carcinoma (HCC) [Withdrawn]

The Treatment of Lapatinib in Combination With Sorafenib in Patients With Advanced Refractory Solid Tumors [Completed]

Dose Escalation Trial of Neoadjuvant Sorafenib and Concurrent Sorafenib, Cisplatin and Radiation in Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN) [Withdrawn]

Sorafenib and Vorinostat in Treating Patients With Advanced Liver Cancer [Suspended]

Phase I Study of Gemcitabine, Sorafenib and Radiotherapy in Patients With Unresectable Pancreatic Cancer [Active, not recruiting]

Sorafenib Trial in Advanced and/or Recurrent Gastric Adenocarcinoma: Treatment Evaluation [Completed]

Sorafenib in Resected Non-small Cell Lung Carcinoma [Terminated]

Combination of Temsirolimus and Sorafenib in the Treatment of Radioactive Iodine Refractory Thyroid Cancer [Active, not recruiting]

Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer [Completed]

Depocyt® With Sorafenib in Neoplastic Meningitis [Terminated]

Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors [Completed]

Safety and Efficacy of Sorafenib in Patients With Advanced Thyroid Cancer: a Phase II Clinical Study [Recruiting]

XIAP Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC) [Completed]

Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma [Completed]

Sorafenib Drug Drug Interaction Study in Healthy Male Subjects [Active, not recruiting]

Chinese Herbal Formulation PHY906 and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer [Active, not recruiting]

Safety and Efficacy Study of CC-122 Combined With Sorafenib for Primary Liver Cancer [Recruiting]

Trial of Sorafenib in Hepatocellular Cancer (HCC) Transplant Patients [Completed]

Investigating Patient Characteristics of Intermediate Stage Hepatocellular Carcinoma Patients Treated With Nexavar and Their Distribution to Different Treatment Groups as Well as Determining Effectiveness and Safety [Active, not recruiting]

Sorafenib and Bortezomib in Treating Patients With Advanced Cancer [Completed]

A Multi-Center, Non-Controlled Clinical Study of Sorafenib Adjuvant Therapy in Advanced Renal-Cell Carcinoma [Recruiting]

Sorafenib in Treating Patients With Locally Advanced or Metastatic Liver Cancer and Cirrhosis [Terminated]

Sorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer [Active, not recruiting]

Study of Everolimus and Sorafenib in Patients With Advanced Thyroid Cancer Who Progressed on Sorafenib Alone [Completed]

Study of Sorafenib and Palliative Radiotherapy in Kidney Cancer That Spreads to the Bone [Completed]

Sorafenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia [Completed]

Bortezomib, Sorafenib Tosylate, and Decitabine in Treating Patients With Acute Myeloid Leukemia [Recruiting]

Safety Study of Sorafenib With Androgen Deprivation and Radiotherapy to Treat Prostate Cancer [Terminated]

Clinical Trial for GALNT14 Genotype - Guided, Sorafenib in Combination With TACE in Hepatocellular Carcinoma [Not yet recruiting]

Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer [Completed]

Sorafenib and Transarterial Chemoembolization for Hepatocellular Carcinoma [Completed]

Nexavar Dosing in Renal Cancer Patients in "Real-life" Setting [Active, not recruiting]

Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-naive Patients With Advanced/Metastatic Bladder Carcinoma [Active, not recruiting]

Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer [Completed]

Velcade and Sorafenib in Unresected or Metastatic Renal Cell Carcinoma [Active, not recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015